<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: <z:hpo ids='HP_0001513'>Obesity</z:hpo> is an important risk factor for the development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, but not <z:hpo ids='HP_0000001'>all</z:hpo> <z:mp ids='MP_0001261'>obese</z:mp> individuals develop this complication </plain></SENT>
<SENT sid="1" pm="."><plain>The clinical signs of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> can often be reversed with <z:hpo ids='HP_0001824'>weight loss</z:hpo>; however, it is unknown whether the skeletal muscle <z:mp ids='MP_0003674'>oxidative stress</z:mp> associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> remains after <z:hpo ids='HP_0001824'>weight loss</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We hypothesised that <z:hpo ids='HP_0011010'>chronic</z:hpo> exposure to high <z:chebi fb="105" ids="17234">glucose</z:chebi> and insulin would re-elicit impaired metabolism in primary myotubes from patients with a history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: <z:mp ids='MP_0001261'>Obese</z:mp> participants with or without type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> completed a standardised <z:hpo ids='HP_0001824'>weight loss</z:hpo> protocol, following which <z:hpo ids='HP_0000001'>all</z:hpo> participants were euglycaemic and had similar indices of insulin sensitivity </plain></SENT>
<SENT sid="4" pm="."><plain>Satellite cells were isolated from muscle biopsies and differentiated under low or high <z:chebi fb="105" ids="17234">glucose</z:chebi> and insulin conditions (HGI) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Cells from participants with no history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> showed robust increases in <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> content, <z:chebi fb="2" ids="50744">citrate</z:chebi> synthase and <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> oxidase activities when exposed to HGI </plain></SENT>
<SENT sid="6" pm="."><plain>This increase in oxidative capacity was absent in cells from patients with a history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>High <z:chebi fb="105" ids="17234">glucose</z:chebi> and insulin caused increased oxidative damage in cells from the latter, despite higher <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase expression </plain></SENT>
<SENT sid="8" pm="."><plain>Cells from patients with a history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> were unable to decrease <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane potential in response to HGI, potentially due to lower levels of uncoupling protein-3 </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS/INTERPRETATION: This is the first report to note that primary myotubes from patients with a history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are unable to adapt to a hyperglycaemic-hyperinsulinaemic challenge </plain></SENT>
<SENT sid="10" pm="."><plain>We have demonstrated that impaired <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> biogenesis and an inability to manage <z:mp ids='MP_0003674'>oxidative stress</z:mp> define a <z:mp ids='MP_0005369'>muscle phenotype</z:mp> at risk of <z:hpo ids='HP_0001513'>obesity</z:hpo>-associated type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>